相关实验视频
Updated: Jul 6, 2025
07:44
A Porcine Model of Acute Autologous Pulmonary Embolism
Published on: September 6, 2024
385
血清白蛋白对急性肺栓塞患者的短期不良预后:基于数据库的临床研究
Jiayong Qiu1,2, Yingying Hao3, Shenshen Huang2
1Department of Respiratory and Critical Care Medicine, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Angiology
|January 9, 2024
概括
血清白蛋白 (ALB) 水平预测急性肺栓塞 (APE) 患者的短期死亡率. 低ALB与较高的死亡风险有关,有助于预测预后.
科学领域:
- 心脏病学 心脏病学
- 肺部病理学 肺部病理学
- 临床生物化学 临床生物化学
背景情况:
- 血清白蛋白 (ALB) 在急性肺栓塞 (APE) 的预后值尚未明确.
- 急性肺栓塞 (APE) 是致病率和死亡率的一个重要原因.
- 了解预后标志物对于有效的患者管理至关重要.
研究的目的:
- 调查血清白蛋白 (ALB) 对被诊断为急性肺栓塞 (APE) 患者的短期死亡率的预测能力.
- 开发一个预测模型和名谱,用于对APE患者的个性化死亡风险评估.
- 评估ALB的诊断性能及其与简化肺栓塞严重性指数 (sPESI) 的结合.
主要方法:
- 基于医院的肺栓塞 (PE) 数据库的回顾性分析,包括340名APE患者.
- 用于预测建模的物流回归分析和名ogram构造.
- 接收器操作特征 (ROC) 曲线分析,以评估ALB和ALB联合sPESI的诊断性能.
主要成果:
- 30天全因死亡率为8.5%,低蛋白血症的发病率为15.9%.
- 较高的血清白蛋白 (ALB) 水平与短期死亡率 (OR=0.89) 的几率比率 (OR) 降低有关.
- 在ALB的曲线下面积 (AUC) 为0.758,最佳切线为33.85g/L. 结合ALB和sPESI,AUC得到了改善,达到0.835.
结论:
- 基线低albuminemia是急性肺栓塞 (APE) 患者短期死亡率的独立指标.
- 血清白蛋白 (ALB) 可以作为APE的有价值的预后标志物.
- 开发的诺米图和组合的sPESI模型为APE患者提供了改进的个性化风险预测.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
159
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
159
01:30Pneumonia III: Complications and Assessment
227
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
227
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
701
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
701
01:28Pneumonia IV: Management
331
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
331